Physician profile
David Chisholm
NPI 1366433419
$3,301.63
in general payments reported to CMS, 2019-2025
39 companies · $481 in 2025
The $481 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $544 · 2021: $1,078 · 2022: $537 · 2023: $79.94 · 2024: $176 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $506.17 | 2019-2024 | Thinprep 2000 Processor, Aptima |
| Abbvie INC. | $386.14 | 2020-2024 | |
| Daiichi Sankyo INC. | $324.60 | 2019-2022 | |
| Coopersurgical, INC. | $316.68 | 2019-2022 | |
| Dexcom, INC. | $193.29 | 2024-2025 | Dexcom G6 Transmitter |
| Exeltis, USA INC. | $143.70 | 2020-2023 | Slynd |
| Merck Sharp & Dohme LLC | $130.07 | 2019-2025 | Vaxneuvance, Gardasil 9, Proquad |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $113.64 | 2025 | Caplyta |
| Myovant Sciences INC. | $105.55 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.73 | 2019-2022 | |
| Therapeuticsmd, INC. | $82.88 | 2020-2022 | |
| Novo Nordisk INC | $81.03 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Lupin INC. | $68.62 | 2019-2021 | |
| Evofem Biosciences, INC. | $63.37 | 2021 | |
| Amag Pharmaceuticals, INC. | $58.57 | 2019-2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chisholm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.